Dr. David Michael Hyman, MD

  • New York, NY
  • Medical oncologist
NPI1477710556
Medicare services, 2019
378
Part D claims, 2019
97
Publications
187
Clinical trials
5
Hospital affiliations
1
Practice address
1275 York Avenue, New York, NY 10065
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Memorial Sloan Kettering Cancer Center

Hospital · New York, New York

Find Dr. Hyman's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. David Michael Hyman is a medical oncologist in New York, New York

Dr. Hyman practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Hyman's NPI, 1477710556, was assigned on May 17, 2008. Dr. Hyman holds New York license 245748.

NPI and contact details
NPI enumeration date
May 17, 2008
NPI status
Active
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. David Michael Hyman practices at Memorial Sloan Kettering Cancer Center in New York, New York

Dr. Hyman's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. David Michael Hyman is affiliated with 1 site of care and 1 medical group

Dr. Hyman's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center.

Sources: Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. David Michael Hyman's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hyman practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Memorial Sloan Kettering Cancer CenterAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Hyman practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. David Michael Hyman is one of 458 medical oncologists in New York

Medical oncology is Dr. Hyman's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Hyman is licensed in New York.

Specialties and state licenses

  • Medical oncology, New YorkPrimaryLicense 245748 · taxonomy 207RX0202X

Medical oncologists near Dr. Hyman

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. David Michael Hyman billed Medicare for 378 services in 2019

CMS data shows 378 Medicare services from Dr. Hyman across 2 procedure codes in 2019. Medicare paid $26,948 for them.

Medicare services, 2019378
Paid by Medicare$26,948
Procedure codes2

Dr. Hyman's Medicare services by type, 2018 to 2019

  • 2018
  • 2019
Office and hospital visits
2018: 3902019: 3783%

Where Dr. Hyman's Medicare services took place, 2019

  • In an office34792%
  • In a facility318%

Dr. Hyman compared with the New York median for medical oncologists, 2019

  • Dr. Hyman
  • New York median
Medicare services
378vs 34011% above
Part D claims
97vs 13025% below

Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.

Dr. Hyman's most billed Medicare procedure codes, 2019

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Hyman

Need commercial claims for Dr. Hyman?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Hyman and other medical oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. David Michael Hyman's patients have a median age of 82

Across all payers, Dmand AI patient panel data puts Dr. Hyman's median patient age at 82, with 100% women.

Dr. Hyman's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 82

Patient panel by sex, all payers

  • Women100%
  • Men0%

Source: Dmand AI Patient Panel Data

Dr. David Michael Hyman wrote 97 Medicare Part D claims in 2019

In 2019, Dr. Hyman wrote 97 Medicare Part D claims. They cover 6 drugs, with $9,744 in total drug cost. In 2018, CMS named 136 claims across 6 drugs.

Part D claims, 201997
Drugs named by CMS6
Total drug cost$9,744

Dr. Hyman's most prescribed drugs by claims, 2019

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2018 to 2019

  • 2018
  • 2019
Claims for drugs CMS names
2018: 1362019: 9729%

Drugs named by CMS: 6 in 2019, 6 in 2018.

See all prescribing by Dr. Hyman

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Hyman by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. David Michael Hyman has 187 publications on record

Dmand AI links 187 papers to Dr. Hyman, published from 2011 to 2024. 2018 was the busiest year, with 26. The most frequent topics are Antineoplastic Agents, Biomarkers, Tumor and Molecular Targeted Therapy. Dr. Hyman has published most often in Clin Cancer Res. Dr. Hyman's most frequent co-authors are Jaclyn Frances Hechtman, MD, Mark E. Robson, MD and Eli Louis Diamond, MD.

Papers187
Years published2011 to 2024

Dr. Hyman's papers by year, 2015 to 2024

Topics Dr. Hyman writes about most

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Molecular Targeted Therapy
  • Genomics
  • Precision Medicine
  • Protein Kinase Inhibitors
  • High-Throughput Nucleotide Sequencing
  • Breast Neoplasms

Dr. Hyman's most frequent co-authors

Recent publications by Dr. Hyman

See all 187 publications and co-authors

See who Dr. Hyman researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Hyman works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. David Michael Hyman has worked on 5 clinical trials

Dmand AI links Dr. Hyman to 5 clinical trials, 2 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Fallopian Tube Diseases, Hematologic Neoplasms and Prostatic Neoplasms. Memorial Sloan Kettering Cancer Center sponsors the most, 2.

Clinical trials with Dr. Hyman by phase

  1. 2Phase 1: 2 trials
  2. 2Phase 2: 2 trials
  3. NonePhase 3: no trials
  4. NonePhase 4: no trials

Conditions in Dr. Hyman's trials

  • Fallopian Tube Diseases
  • Hematologic Neoplasms
  • Prostatic Neoplasms
  • Thyroid Neoplasms
  • Fallopian Tube Neoplasms

Investigators on the most trials with Dr. Hyman

Recent clinical trials with Dr. Hyman

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. David Michael Hyman received $43,235 in industry payments from 2016 to 2023

CMS Open Payments shows 63 general payments to Dr. Hyman from 11 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 58% of the total. Genentech, Inc. paid the most, $28,208. It also lists 4 research payments totaling $29,745 from 2018 to 2020.

General payments to Dr. Hyman by program year, 2016 to 2023

General payments to Dr. Hyman by kind, 2016 to 2023

$43.2Kin total
  • Consulting fees$25,22858%
  • Travel and lodging$13,92832%
  • Food and beverage$2,4046%
  • Speaker and faculty fees$1,6764%

Companies that paid Dr. Hyman the most, 2016 to 2023

Share is of all general payments to this clinician.

See all payments to Dr. Hyman

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. David Michael Hyman's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Primary practice, affiliations and health systemDmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. David Michael Hyman

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. David Michael Hyman's NPI number?

Dr. David Michael Hyman's NPI number is 1477710556. It was assigned on May 17, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. David Michael Hyman?

Dr. David Michael Hyman is a medical oncologist in New York, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. David Michael Hyman practice?

Dr. Hyman practices at 1275 York Avenue, New York, NY 10065. Dr. Hyman's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

What is Dr. David Michael Hyman's medical license number?

Dr. Hyman holds New York license 245748.

Which hospitals is Dr. David Michael Hyman affiliated with?

Dr. Hyman practices at Memorial Sloan Kettering Cancer Center in New York, New York.

What medical group is Dr. David Michael Hyman part of?

Dr. Hyman is linked to Memorial Sloan Kettering Cancer Center.

Does Dr. David Michael Hyman accept Medicare?

Yes. CMS data shows Dr. Hyman billed Medicare for 378 services in 2019.

What services does Dr. David Michael Hyman bill to Medicare?

In 2019, Dr. Hyman's most billed Medicare services were office visit, established patient (99214) and hospital inpatient care (99233).

What drugs does Dr. David Michael Hyman prescribe most?

In 2019 Medicare Part D data, Dr. Hyman's most prescribed drugs by claims were Dexamethasone, Ondansetron HCl and Xarelto.

Has Dr. David Michael Hyman received payments from drug or device companies?

CMS Open Payments shows $43,235 in general payments to Dr. Hyman from 11 companies from 2016 to 2023. The largest total came from Genentech, Inc.

Show 3 more questionsShow fewer questions

How long has Dr. David Michael Hyman been practicing?

Dr. Hyman's NPI was assigned in 2008.

Does Dr. David Michael Hyman do research?

Dmand AI links 187 publications to Dr. Hyman, published from 2011 to 2024. Dr. Hyman has worked on 5 clinical trials.

Who does Dr. David Michael Hyman publish with?

Dr. Hyman's most frequent co-authors are Jaclyn Frances Hechtman, MD (21 shared papers), Mark E. Robson, MD (21 shared papers) and Eli Louis Diamond, MD (19 shared papers).

Selling to medical oncology practices?

See medical oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)